The dog treated with RECONCILE chewable tablets was subsequently diagnosed with vestibular disease and the control dog had a history of recurrent hind leg weakness. In a European multi-site study, 234 dogs were treated with daily doses of fluoxetine chewable tablets ranging from 0.25 mg/kg to 4 mg/kg. One dog treated with a daily dose of 0.4 mg/kg for one month experienced one seizure one week after discontinuing therapy.
RPRâs core mission is to reinforce the REALTORÂ®'s value in the marketplace by keeping them ahead of the technology curve and better able to serve todayâs technology empowered consumer. Realtors Property ResourceÂ® (RPRÂ®) is NAR's exclusive online real estate database. RPRâs core mission is to reinforce the REALTORÂ®'s value in the marketplace by keeping them ahead of the technology curve and better able to serve todayâs technology empowered consumer.
Retinitis pigmentosa (RP) refers to a group of inherited diseases causing retinal degeneration. The cell-rich retina lines the back inside wall of the eye. The cells within the retina capture and process images which are then transmitted through the optic nerve to the brain. People with RP experience a gradual decline in their vision because retinal photoreceptor cells (rods and cones) die. Forms of RP and related diseases include Usher syndrome, Leberâs congenital amaurosis (LCA), rod-cone disease, Bardet-Biedl syndrome, and choroidermia, among others.